A Dedicated Focus On Food And Drug Law And Business Litigation Matters

If you are in an industry that in any way involves food, dietary supplements, over-the-counter drugs, medical devices, cosmetics or the packaging that contains them, it is important that you have dedicated counsel from a firm that knows the law and has the ability to help you ensure compliance. For more than 30 years, attorney Eric Greenberg and his team at Eric F. Greenberg, P.C., have been protecting clients’ business interests through strategic planning and skillful representation.

Our dedicated focus on food and drug law and packaging law allows us to provide innovative and comprehensive compliance solutions. A large portion of our practice is dedicated to advising clients on compliance requirements and the steps that need to be taken in order to remain compliant with Food and Drug Administration (FDA) regulations. Over the years, we have also developed a robust business litigation practice that includes services for contract disputes and the protection of trade secrets.

Our clients appreciate the personalized service they receive from our attorneys. We work closely with corporate officers and other key personnel in order to fully understand your business needs and deliver the most timely and relevant service possible.

To learn more about our Chicago, Illinois-based lawyers and other personnel, please select a link from the list below.

Principal Attorney

Senior Attorney

Senior Scientist

Contact Us To Discuss Your Legal Needs

We invite you to schedule an initial consultation to learn more about our law firm’s food and drug law services. You can reach us by phone at 312-977-4647 or via email for an initial consultation.

Our firm is a proud member of the International Network of Boutique Law Firms, a select organization with member law firms throughout the United States and “strategic partners” around the world.

International Network of Boutique and Independent Law Firms badge

GRAS Goes to Congress

GRAS Goes to Congress

By Eric F. Greenberg, Attorney-at-law

Remember that whole business involving NGOs and other folks objecting to the legal system that allows companies to self-determine that their uses of substances are Generally Recognized As Safe (“GRAS”)? And remember how some groups had gone to court to get the system declared unlawful, but late last year the court ruled against them? Well, there’s a new chapter to this story. Now, some members of Congress have proposed a bill that would make changes to the law to address those very same objections.

The GRAS pathway to clearance of the use of substances in packaging and in food is crucially important, and this proposed law has the potential to make enormous changes in various legal obligations. For that reason, packagers should keep a close eye on this latest chapter in the ongoing debate over the policy issues surrounding the GRAS system.

In my view, addressing the complaints we’ve heard for years about the GRAS program required changes in the law, so at least the objectors are in the correct forum. There’s been so much criticism of the Food and Drug Administration lately, what with its slow reaction to the infant formula contamination problem, on top of its handling of issues relating to heavy metals in baby food and various complaints about its handling of COVID and other drug approvals, for some examples. But when it comes to the GRAS program, it’s always seemed that most of the objectors’ objections were better directed at Congress than at FDA.

You have questions, We have answers. Request a consult.

Our Office Location

303 East Wacker Drive Suite 305
Chicago, IL 60601

Phone: 312-977-4647